Some doctors who prescribe the GLP-1 meds have become alarmed by the disproportionate loss of muscle mass in their older patients.

Liraglutide had been approved in 2010 as antidiabetic therapy for adults. So far, there was no firm evidence of adverse effects on humans.

The pharmaceutical industry is eagerly investigating new applications for GLP-1s, but the real opportunity lies in precision medicine.

Regarding the currently existing GLP-1 RA meds, there are a few widely recognized contraindications.

The vagus nerve has been compared to an “information superhighway” that conveys messages from the gut to the brain.

The vagus nerve connects the brain to the heart, lungs, digestive tract, and several other entities. Why is it so important?

For many U.S. parents seeking help for a child with obesity, the most widely endorsed treatment — behavioral counseling — is out of reach. Here’s why.

A recent JAMA Network Open study assessed the effectiveness of web-based self-help interventions in alleviating binge eating disorder (BED).

The world has a lot to say about binge eating. Sometimes the search for a more precise definition leads off into fascinating side roads.

Eventually, GLP-1 drugs might become available as generics, possibly eliminating the need for cheaper alternatives. But for now, affordability is a major issue.

Dr. Meule warns about making unwarranted assumptions about certain eating disorders and their relation to classically-framed addiction.

Severe childhood obesity can drastically reduce life expectancy, cutting it nearly in half, according to a recent global study.

Soluble dietary fiber has long been recommended for its stomach-filling effect. It has been found to slow gastric emptying and increase perceived satiety.

European Congress on Obesity reveals intriguing findings about the source of sugar and how it relates to childhood obesity.

Today’s post checks out the remaining causes that were examined in a 2009 paper, to see how they have held up over time.

GLP-1 weight loss drugs recently came under scrutiny for their potential psychiatric side effects.

Does sleep duration affect the biological mediators of energy homeostasis and appetite? Apparently, yes.

Over the years, Childhood Obesity News has pointed the finger at numerous villains who share varying degrees of culpability for obesity.

The rise of GLP-1 medications is reshaping consumer habits and posing challenges to various sectors of the food and beverage industry.

It is so easy to slide back into the judgmental, punitive version of theorizing about obesity’s origins and blame every obese person directly.

We discuss a paper that cast doubt on or debunked some commonly held beliefs about the causes of obesity and supported others.

GLP-1 agonist drugs like Ozempic, Wegovy, Mounjaro, and Zepbound are showing promise for treating various conditions beyond their original scope.

This is an extension of the recent post that discusses a 2009 paper that looked closely at many accepted or alleged causes of obesity.

Obesity appears to follow the pattern of having not only a gigantic, pervasive cause or two, but an arsenal of little tricks to bring people under its sway.

A look at how Ozempic may increase fertility and why experts caution hopeful parents against using the drug.

Research shows that children and adolescents are experiencing obesity on a scale that would have been impossible to imagine, say, back in the 1990s.

We continue looking at the latest headlines in the fascinating and controversial world of GLP-1 weight loss drugs.

A Swedish study suggests that obese children may face more than double the risk of developing multiple sclerosis as adults.

As childhood obesity just grows and grows, the need for a precise obesity metric is more crucial than ever. This is where waist-to-height ratio comes in.

No surprise there, but both children and adults are vulnerable to having their lives negatively impacted by junk food advertising.